Phreesia, Inc. (PHR)
Stock Price Chart
Key Info
| Market Cap | 1.43B |
| Revenue (ttm) | 134.06M |
| Net Income (ttm) | -18.59M |
| Shares Out | 37.97M |
| EPS (ttm) | -0.51 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Oct 22, 2020 |
| Last Price | $37.61 |
| Previous Close | $36.28 |
| Change ($) | 1.33 |
| Change (%) | 3.67% |
| Day's Open | 36.99 |
| Day's Range | 36.04 - 37.97 |
| Day's Volume | 1,288,504 |
| 52-Week Range | 16.01 - 37.97 |
More Stats
| Market Cap | 1.43B |
| Enterprise Value | 1.37B |
| Earnings Date (est) | Dec 14, 2020 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 37.97M |
| Float | 27.47M |
| EPS (basic) | 0.95 |
| EPS (diluted) | -0.51 |
| FCF / Share | -0.43 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
| Payout Ratio | n/a |
| Shares Short | 1.39M |
| Short Ratio | 2.75 |
| Short % of Float | 5.06% |
| Beta | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| P/FCF Ratio | n/a |
| PS Ratio | 10.65 |
| PB Ratio | 12.75 |
| Revenue | 134.06M |
| Operating Income | -18.18M |
| Net Income | -18.59M |
| Free Cash Flow | -16.36M |
| Net Cash | 53.51M |
| Net Cash / Share | 1.41 |
| Gross Margin | 59.72% |
| Operating Margin | -13.56% |
| Profit Margin | -13.90% |
| FCF Margin | -12.21% |
| ROA | -7.03% |
| ROE | -18.54% |
| ROIC | -37.30% |
Analyst Summary
Analyst Consensus: Buy
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 |
|---|---|---|---|
| Revenue | 125 | 99.89 | 79.83 |
| Revenue Growth | 24.92% | 25.12% | - |
| Gross Profit | 80.06 | 62.89 | 50.06 |
| Operating Income | -15.30 | -9.49 | -14.55 |
| Net Income | -20.29 | -15.06 | -18.19 |
| Shares Outstanding | 20.30 | 1.84 | 1.54 |
| Earnings Per Share | -4.50 | -24.53 | -24.81 |
| Operating Cash Flow | 0.83 | -2.13 | -11.14 |
| Capital Expenditures | -12.32 | -9.83 | -11.97 |
| Free Cash Flow | -11.49 | -11.96 | -23.11 |
| Cash & Equivalents | 90.32 | 1.54 | 10.50 |
| Total Debt | 23.86 | 32.29 | 22.93 |
| Net Cash / Debt | 66.45 | -30.74 | -12.43 |
| Assets | 159 | 59.26 | 57.14 |
| Liabilities | 56.89 | 63.75 | 48.53 |
| Book Value | 102 | -211 | -168 |
Company Profile
Company Details
| Full Name | Phreesia, Inc. |
| Country | United States |
| Employees | 532 |
| CEO | Chaim Indig |
Stock Information
| Ticker Symbol | PHR |
| Stock Exchange | New York Stock Exchange |
| Sector | Healthcare |
| Industry | Health Information Services |
| Unique Identifier | NYSE: PHR |
| IPO Date | July 18, 2019 |
Description
Phreesia provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company's Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. It deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a Web-based dashboard for providers; PhreesiaPads, which are self-service intake tablets; and Arrivals Stations that are on-site kiosks. The company's Phreesia Platform also provides a registration solution to automate patient self-registration; patient activation solution that enables providers to communicate with their patients through surveys, announcements, messaging, and health campaigns; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; clinical support solution that collects clinical intake and PRO data for approximately 25 specialties; appointments solution for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and life sciences, pharmaceutical, medical device, and biotechnology companies. Phreesia, Inc. has a strategic alliance agreement with Allscripts Healthcare, LLC. The company was founded in 2005 and is headquartered in New York, New York.